Jennison Associates’s 89bio ETNB Stock Holding History

Jennison Associates’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-234,190	Closed	-$2.3M	–	596
2025 Q2	$2.3M	Buy	+234,190	New	+$1.94M	﹤0.01%	432

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jennison Associates's ETNB Position: Q3 2025 in Review

Jennison Associates sold out of 89bio (ETNB) in Q3 2025, closing a stake of 234,190 shares — an estimated $2.3M sold.

Jennison Associates first reported a position in ETNB in Q2 2025 and held it in 1 quarter. The position peaked at $2.3M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

Jennison Associates reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
Jennison Associates sold 234,190 89bio shares in Q3 2025, an estimated $2.3M.
Jennison Associates first reported a position in 89bio in Q2 2025 and held it in 1 quarter.
Jennison Associates's 89bio position peaked at $2.3M in Q2 2025.
198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.